"Rep. Chris Collins (R-NY) has targeted infusion drugs for removal from a federal program called 340B. The program requires pharmaceutical companies that participate in Medicaid to sell drugs to certain hospitals at deep discounts, some as much as 50 percent. The majority of those drugs are...
"The opioid epidemic, and the rapidly increasing rash of high drug prices, are the twin deadly sins of the modern pharmaceutical industry. Any serious pro-patient policy analyst in Washington will likely acknowledge this. The responsibility of companies like the makers of Oxycontin for the spread of opioids...
"Right now, policy developments in Washington, D.C., are placing rural North Dakota hospitals and other healthcare providers at significant risk of shutting down, choking off healthcare access for thousands of patients in rural communities who have few other options. In January, an agency in Washington,...
"AIDS Healthcare Foundation (AHF) continues to sound the alarm that a nationwide drug discount pricing program vital to the country’s health care safety net – and its HIV/AIDS response – is once again under attack by the drug industry under the guise of ‘reform.’ This week,...
"On top of an expected increase in uninsured patients, proposed cuts to a drug discount program would further threaten their bottom line, local hospital officials say. 'The change that was proposed ...
"It’s a rite of passage for executives in the hot seat: get hauled before Congress, sit for bipartisan tirades, squirm in the face of difficult questioning. Over the past six months, lawmakers have dragged in former Equifax CEO Richard Smith, Wells Fargo’s Tim Sloan, and Amtrak’s...
"HHS has made its fifth request to delay a rule that would set new drug ceiling prices in the 340B drug discount program. The rule was supposed to kick in July 1. On Tuesday, HHS asked the White House's Office of Management and Budget to push...
"The soaring cost of prescription drugs threatens access to life-saving medications for millions of people across the country and thousands of Hoosiers here at home. For these vulnerable patients, safety net health care providers — supported by the 340B Drug Pricing Program — make all...
"The debate over the future of the 340B drug pricing program has reached a critical new phase. Several members of Congress introduced legislation that would make dramatic changes in the 26-year-old statute, Congress is holding hearings on the program and the Trump administration has offered new proposals...
"Two things are true now, more than ever before: health care is expensive and prescription drug prices are sky-high. Indiana residents — especially those in rural areas, who have to travel long distances for a doctor — are struggling to seek treatment and afford medication. This...
